Virus News and Research

Latest Virus News and Research

Novel SARS-CoV-2 neutralizing antibody enters Phase 1/2a clinical study

Cologne University Hospital (UKK), University of Marburg (UMR), the German Center for Infection Research (DZIF) and Boehringer Ingelheim today announced the initiation of Phase 1/2a clinical investigation of BI 767551, a new SARS-CoV-2 neutralizing antibody.

18 Dec 2020

Pandemic-related paid sick days and leave to expire Dec. 31 — with no extension in sight

Like tens of millions of other parents nationwide, Jonathan and Sara Sadowski struggle to assist their four children, ages 5 to 11, with their online schooling at home. In addition, their eldest child, who has cerebral palsy and is in a wheelchair, needs special care.

18 Dec 2020

Very few COVID-19-positive children require hospitalization, finds case study

A team of researchers at the Divisions of Infectious Diseases, UPMC Children’s Hospital of Pittsburgh and the University of Pittsburgh, USA, sought to characterize the clinical presentation of children with COVID-19 in Western Pennsylvania.

18 Dec 2020

Remdesivir inhibits SARS-CoV-2 replication by preventing RdRp-mediated RNA translocation

A new study describes the in vitro mechanism by which remdesivir kinetically inhibits the replication of the virus that causes COVID-19, SARS-CoV-2.

18 Dec 2020

Rapid no-frills detection of SARS-CoV-2 in saliva with LAMP-Cas13

A new paper that appeared as a preprint on the medRxiv* server in December 2020 describes a nucleic acid test validated on saliva samples.

18 Dec 2020

Rapid point-of-care lateral flow assay to assess the neutralizing activity of plasma against SARS-CoV-2

A new paper describes the development and validation of a rapid test to measure the neutralizing activity of serum against COVID-19 using a drop of blood.

18 Dec 2020

Could neurological complications be common even in mild COVID-19?

News-Medical talks to Dr. Pria Anand about her research into COVID-19 that suggests neurologic complications are common even in mild infections.

18 Dec 2020

AAHMS report spells out the necessary steps to maintain control over COVID-19 in 2021

High levels of testing, efficient vaccine distribution and addressing pandemic mental health impacts are critical if Australia is to maintain control over COVID-19 in 2021, the country’s learned body for health and medical sciences has concluded.

18 Dec 2020

Study: At least a fifth of the world’s population may not have access to covid-19 vaccine until 2022

Nearly a quarter of the world’s population may not have access to a covid-19 vaccine until at least 2022, warns a study published by The BMJ today.

18 Dec 2020

UEA study offers recommendations to reduce Covid-19 transmission in universities

Universities should keep their windows fully open and students shouldn’t share personal items – according to new University of East Anglia research into reducing the spread of Covid-19.

18 Dec 2020

Experts to share the lessons learnt from COVID-19 first wave

The Physiological Society and the Intensive Care Society have come together to host an exciting three-day virtual conference this week, which will review the challenges of understanding the pathophysiological changes occurring throughout the body following COVID-19 infection.

18 Dec 2020

Abbott gets CE Mark for new quantitative SARS-CoV-2 IgG lab-based serology test

Abbott announced today it received CE Mark for its new quantitative SARS-CoV-2 IgG (Immunoglobulin G) lab-based serology test.

18 Dec 2020

West Nile virus-infected mosquitoes are abundant in lower-income areas of Baltimore

In a new study published in the Journal of Medical Entomology, researchers at the University of Maryland (UMD) found higher rates of West Nile virus-infected mosquitoes in lower-income neighborhoods in urban areas of Baltimore, Maryland.

18 Dec 2020

COVID-19 particles will remain infectious as temperature begins to drop

Winter is coming in the northern hemisphere and public health officials are asking how the seasonal shift will impact the spread of SARS-CoV-2, the virus that causes COVID-19?

18 Dec 2020

COVID-19 pandemic highlights the risk of using systemic corticosteroids

Healthcare workers in tropical and sub-tropical settings where strongyloidiasis is prevalent or caring for patients who have travelled to such areas, need to maintain a high level of awareness about the use of corticosteroids, including when this class of anti-inflammatories is given to patients suspected of infection with SARS-CoV-2.

17 Dec 2020

Research shows that people affected with COVID-19 suffer from cognitive effects

More and more evidence is coming out that people with COVID-19 are suffering from cognitive effects, such as brain fog and fatigue.

17 Dec 2020

Supercomputer simulations lead to an important viral inhibitor discovery

University of New Hampshire researchers recently used Comet at the San Diego Supercomputer Center at UC San Diego and Stampede2 at the Texas Advanced Computing Center to identify new inhibitor binding/unbinding pathways in an RNA-based virus.

17 Dec 2020

Continued vigilance is required in England following exit from second lockdown

Researchers in the UK have presented data from the latest in a series of community surveys assessing the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in England.

17 Dec 2020

Study highlights how the sex differences in COVID-19 are linked to ACE2 protein

Female COVID-19 patients face less severe disease complications and a lower risk of dying than male patients thanks to hormones and chromosomes that contribute to a stronger immune response, according to new research from a University of Alberta-led team.

17 Dec 2020

KHN’s ‘What the Health?’: All I want for Christmas is a COVID relief bill

Congress appears to be inching ever closer to agreement on a long-delayed COVID-19 relief bill, which would extend unemployment insurance and other emergency programs set to expire in the next several days.

17 Dec 2020

Virus News and Research

Latest Virus News and Research

Novel SARS-CoV-2 neutralizing antibody enters Phase 1/2a clinical study

Pandemic-related paid sick days and leave to expire Dec. 31 — with no extension in sight

Very few COVID-19-positive children require hospitalization, finds case study

Remdesivir inhibits SARS-CoV-2 replication by preventing RdRp-mediated RNA translocation

Rapid no-frills detection of SARS-CoV-2 in saliva with LAMP-Cas13

Rapid point-of-care lateral flow assay to assess the neutralizing activity of plasma against SARS-CoV-2

Could neurological complications be common even in mild COVID-19?

AAHMS report spells out the necessary steps to maintain control over COVID-19 in 2021

Study: At least a fifth of the world’s population may not have access to covid-19 vaccine until 2022

UEA study offers recommendations to reduce Covid-19 transmission in universities

Experts to share the lessons learnt from COVID-19 first wave

Abbott gets CE Mark for new quantitative SARS-CoV-2 IgG lab-based serology test

West Nile virus-infected mosquitoes are abundant in lower-income areas of Baltimore

COVID-19 particles will remain infectious as temperature begins to drop

COVID-19 pandemic highlights the risk of using systemic corticosteroids

Research shows that people affected with COVID-19 suffer from cognitive effects

Supercomputer simulations lead to an important viral inhibitor discovery

Continued vigilance is required in England following exit from second lockdown

Study highlights how the sex differences in COVID-19 are linked to ACE2 protein

KHN’s ‘What the Health?’: All I want for Christmas is a COVID relief bill

A new way of characterising biomolecules eBook

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Newsletters you may be interested in